PINNACLE ASSOCIATES LTD - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$7,639,832
-13.4%
259,329
-4.1%
0.14%
-7.2%
Q2 2023$8,819,176
-10.5%
270,361
-3.4%
0.15%
-24.3%
Q1 2023$9,853,411
-24.5%
280,006
-1.7%
0.20%
-28.9%
Q4 2022$13,047,016
-7.1%
284,745
-1.8%
0.28%
-11.8%
Q3 2022$14,043,000
+19.1%
289,851
-3.4%
0.32%
+25.3%
Q2 2022$11,793,000
+6.3%
300,146
-0.4%
0.26%
+31.1%
Q1 2022$11,097,000
-22.8%
301,464
-4.4%
0.20%
-21.0%
Q4 2021$14,366,000
+26.7%
315,192
-0.6%
0.25%
+18.7%
Q3 2021$11,337,000
+73.9%
317,215
-3.7%
0.21%
+77.1%
Q2 2021$6,519,000
-13.6%
329,395
+1.6%
0.12%
-18.1%
Q1 2021$7,543,000
+0.9%
324,299
-9.8%
0.14%
-5.3%
Q4 2020$7,475,000
-10.1%
359,724
-6.3%
0.15%
-22.8%
Q3 2020$8,315,000
-11.6%
384,061
-3.8%
0.20%
-15.1%
Q2 2020$9,409,000
+98.1%
399,178
-0.9%
0.23%
+61.1%
Q1 2020$4,750,000
-5.6%
402,893
-15.1%
0.14%
+30.9%
Q4 2019$5,034,000
-14.9%
474,476
-8.7%
0.11%
-20.9%
Q3 2019$5,913,000
-3.9%
519,571
-5.0%
0.14%
-3.5%
Q2 2019$6,150,000
+26.6%
546,646
-9.0%
0.14%
+30.9%
Q1 2019$4,857,000
+29.7%
600,388
+1.3%
0.11%
+13.4%
Q4 2018$3,746,000
-41.4%
592,778
-8.7%
0.10%
-27.1%
Q3 2018$6,396,000
+1.6%
649,291
-14.4%
0.13%
+3.1%
Q2 2018$6,294,000
-1.6%
758,325
-14.6%
0.13%
+3.2%
Q1 2018$6,397,000
-10.6%
888,415
+1.2%
0.12%
-8.8%
Q4 2017$7,152,000
-51.1%
877,575
-13.0%
0.14%
-49.3%
Q3 2017$14,628,0001,008,8050.27%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders